Literature DB >> 11532490

Birth after intracytoplasmic sperm injection with use of testicular sperm from men with Kartagener/immotile cilia syndrome.

S Cayan1, J Conaghan, E D Schriock, I P Ryan, L D Black, P J Turek.   

Abstract

OBJECTIVE: To describe two cases of in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI) with testicular sperm in men with immotile cilia syndromes.
DESIGN: Case report.
SETTING: A university-based male infertility clinic and assisted reproduction unit. PATIENT(S): Two couples with male factor infertility due to Kartagener/immotile cilia syndrome. INTERVENTION(S): IVF/ICSI with testicular sperm. MAIN OUTCOME MEASURE(S): Semen characteristics, sperm viability, fertilization rate, and pregnancy. RESULT(S): With testicular sperm, the two pronuclear fertilization rates were 63% and 60% in two cases. One case resulted in the birth of normal healthy girl. CONCLUSION(S): With testicular sperm, successful oocyte fertilization after ICSI in couples with male Kartagener/immotile cilia syndrome is possible despite the lack of sperm motility.

Entities:  

Mesh:

Year:  2001        PMID: 11532490     DOI: 10.1016/s0015-0282(01)01974-4

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  10 in total

Review 1.  Tales of the tail and sperm head aches: changing concepts on the prognostic significance of sperm pathologies affecting the head, neck and tail.

Authors:  Héctor E Chemes; Cristian Alvarez Sedo
Journal:  Asian J Androl       Date:  2011-12-26       Impact factor: 3.285

2.  A case of primary ciliary dyskinesia treated with ICSI using testicular spermatozoa: case report and a review of the literature.

Authors:  Akiko Kawasaki; Hajime Okamoto; Atsushi Wada; Yoko Ainoya; Naoki Kita; Tetsuro Maeyama; Naoko Edamoto; Hiroyuki Nishiyama; Sadamu Tsukamoto; Akira Joraku; Natsui Waku; Hiroyuki Yoshikawa
Journal:  Reprod Med Biol       Date:  2015-05-19

3.  Successful twin birth following blastocyst culture of embryos derived from the immotile ejaculated spermatozoa from a patient with primary ciliary dyskinesia: a case report.

Authors:  Richard J Kordus; Robert L Price; Jeffrey M Davis; Gail F Whitman-Elia
Journal:  J Assist Reprod Genet       Date:  2008-10-15       Impact factor: 3.412

Review 4.  The biology of infertility: research advances and clinical challenges.

Authors:  Martin M Matzuk; Dolores J Lamb
Journal:  Nat Med       Date:  2008-11-06       Impact factor: 53.440

Review 5.  Genetic factors in assisted reproduction.

Authors:  Christian J Gruber; Markus Hengstschläger; Heinz Leipold; Isabel M Gruber; Kathrin Ferlitsch; Doris M Gruber; Johannes C Huber
Journal:  Wien Klin Wochenschr       Date:  2003-12-15       Impact factor: 1.704

6.  Healthy twin live-birth after ionophore treatment in a case of theophylline-resistant Kartagener syndrome.

Authors:  T Ebner; M Maurer; P Oppelt; R B Mayer; H C Duba; W Costamoling; O Shebl
Journal:  J Assist Reprod Genet       Date:  2015-05-10       Impact factor: 3.412

7.  Selective use of percutaneous testis biopsy to optimize IVF-ICSI outcomes: a case series.

Authors:  Russell P Hayden; Diane L Wright; Thomas L Toth; Cigdem Tanrikut
Journal:  Fertil Res Pract       Date:  2016-04-15

8.  Live birth after Laser Assisted Viability Assessment (LAVA) to detect pentoxifylline resistant ejaculated immotile spermatozoa during ICSI in a couple with male Kartagener's syndrome.

Authors:  Sinan Ozkavukcu; Ciler Celik-Ozenci; Esma Konuk; Cem Atabekoglu
Journal:  Reprod Biol Endocrinol       Date:  2018-02-05       Impact factor: 5.211

Review 9.  The Role of Sperm Centrioles in Human Reproduction - The Known and the Unknown.

Authors:  Tomer Avidor-Reiss; Matthew Mazur; Emily L Fishman; Puneet Sindhwani
Journal:  Front Cell Dev Biol       Date:  2019-10-01

Review 10.  Management of primary ciliary dyskinesia/Kartagener's syndrome in infertile male patients and current progress in defining the underlying genetic mechanism.

Authors:  Yan-Wei Sha; Lu Ding; Ping Li
Journal:  Asian J Androl       Date:  2014 Jan-Feb       Impact factor: 3.285

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.